PHC Achieves Additional Contract for Antigen Diagnostic Kits Worth Approximately 14.3 Billion KRW in Malaysia

[Asia Economy Reporter Jang Hyowon] PHC (CEO Choi Inhwan) announced on the 19th that it has signed a supply contract for antigen test kits worth approximately 14.3 billion KRW.

The signed supply contract is scheduled to supply to Malaysia, with the supply period lasting until the end of July 2022.

PHC's antigen test kits have been approved domestically as nasopharyngeal products, but have obtained local approval for dual use with saliva in Europe, Austria, and Malaysia.

This antigen test kit was registered as the first saliva antigen test home kit in Malaysia, and the supply contract was signed simultaneously upon approval completion.

In clinical trials conducted locally, the sensitivity of the antigen test kit was reported to reach 90.6%, comparable to PCR tests. The measurement method using saliva is simple to use, and reading and transmission via an APP is possible, making it highly versatile.

The Malaysian government implemented lockdowns on economic and social activities on the 1st of last month as the spread of COVID-19 did not subside. However, due to the spread of the Delta variant, the number of daily confirmed cases recently exceeded 10,000, and there have been cluster infections among volunteers and staff at vaccination centers who have completed full vaccination, intensifying the spread.

The company plans to actively increase export volume by leveraging its experience already established in Malaysia. PHC signed a supply contract worth 3.2 billion KRW for rapid antigen test kits in Malaysia in March last year and completed full delivery in March this year.

In addition to Malaysia and other Southeast Asian countries, PHC continues to export COVID-19 related products to various countries. These include specimen collection kits and rapid antigen test kits, and in June, the company succeeded in signing an export contract for neutralizing antibody test kits worth approximately 10.4 million USD with the United States.

A PHC representative said, "This antigen test kit is recognized for its excellence not only in accuracy but also for its simple measurement method," adding, "At this point when many people are commonly affected by the Delta variant, our company will contribute at the forefront of COVID-19 prevention."

This content was produced with the assistance of AI translation services.